Anavex Life Sciences Corp (AVXL)

[raja48185]

Is phase2/3 = phase 3 ? or more like phase 2 unless the results are so good that it can be deemed to be phase 3; else do a phase 3

October 2022 for TLR ? quite possible, but I would not bank on it ; not when the clinical trials site has these dates (see below) and going by the way it has been all along - even though the primary and secondary outcome measures are assessed at 96 weeks (time frame)

https://clinicaltrials.gov/ct2/show/NCT04314934?term=Anavex+Life+Sciences&draw=4&rank=1

Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 450 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Open Label Extension Study for Patients With Early Alzheimer's Disease (AD) Enrolled in Study ANAVEX2-73-AD-004

Actual Study Start Date : October 10, 2019
Estimated Primary Completion Date : May 2024
Estimated Study Completion Date : June 2024